Results 11 to 20 of about 317,847 (188)
EV-D68 neurological disease: tipping the scales toward immunopathogenesis. [PDF]
Over the last decade, there have been multiple outbreaks of enterovirus D68 (EV-D68) disease and associated cases of acute flaccid myelitis (AFM). The underlying cause of EV-D68–induced AFM is contentious; whether spinal cord motor neurons are damaged by direct viral infection, infiltration of immune cells, or a combination of both
Krug PW.
europepmc +5 more sources
Structural insights from vaccine candidates for EV-D68. [PDF]
Enterovirus D68 (EV-D68), a member of the Picornaviridae family, causes respiratory illness and can lead to acute flaccid myelitis in children. No specific treatment or vaccine is available. Here, we determine cryo-EM structures of EV-D68 virus-like particles (VLPs), inactivated virus particles (InVPs), and altered virus particles (A-particles) from B3
Cheng J +12 more
europepmc +5 more sources
Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68). [PDF]
Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases. In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, especially young children and immunocompromised individuals. There is currently no
Musharrafieh R +7 more
europepmc +5 more sources
Changes in transmission of Enterovirus D68 (EV-D68) in England inferred from seroprevalence data. [PDF]
Abstract The factors leading to the global emergence of enterovirus D68 (EV-D68) in 2014 as a cause of acute flaccid myelitis (AFM) in children are unknown. To investigate potential changes in virus transmissibility or population susceptibility, we measured the seroprevalence of EV-D68-specific neutralising antibodies in serum samples ...
Pons-Salort M +6 more
europepmc +8 more sources
In vitro and in vivo models for the study of EV-D68 infection [PDF]
Enterovirus D68 (EV-D68) is one of hundreds of non-polio enteroviruses that typically cause cold-like respiratory illness. The first EV-D68 outbreak in the United States in 2014 aroused widespread concern among the public and health authorities.
Yuan Teng Hooi +1 more
openaire +3 more sources
Seasonal EV-D68 infections can strain medical care resources due to increased pediatric hospitalizations for respiratory illness. In this study, we examine Kansas City's 2022 EV-D68 season. Rhinovirus/enterovirus (RV/EV) positive respiratory specimens from standard of care testing were salvaged and tested by EV-D68 specific PCR. Of the 1412 respiratory
Stephanie Gummersheimer +8 more
core +4 more sources
Enterovirus D68 – The New Polio? [PDF]
Enterovirus D68 (EV-D68) has emerged over the recent years, with large outbreaks worldwide. Increased occurrence has coincided with improved clinical awareness and surveillance of non-polio enteroviruses.
Hayley Cassidy +4 more
doaj +3 more sources
SNAP23 is essential for germination of EV-D68 replication organelles. [PDF]
Picornaviruses rearrange host cell membranes to facilitate their own replication. Here we investigate the Qbc SNARE, SNAP23, which is found at the plasma membrane and plays roles in exocytosis. We found that knockdown of SNAP23 expression inhibits virus replication but not release from cells.
Miller K +3 more
europepmc +3 more sources
Additional file 1: Figure S1. EV-D68- and EV-A71-specific IgG1 and IgG2c responses in sera of mice. Figure S2. Comparative assessment of the virulence of diverse enterovirus strains, infection routes, and inoculation titres in ICR mice.
Lin, Yu-Li +9 more
openaire +2 more sources
Emerging Therapeutics in the Fight Against EV-D68: A Review of Current Strategies. [PDF]
ABSTRACT Enterovirus‐D68 (EV‐D68) was first identified in 1962 in pediatric patients with acute respiratory conditions in California, USA (US). From the 1970s to 2005, EV‐D68 was underestimated due to limited data and serotyping methods.
Kalam N, Balasubramaniam VRMT.
europepmc +3 more sources

